ACTH vs Vigabatrin in Infantile Spasms
J Gordon Millichap
Abstract
J Gordon Millichap
Abstract
The comparative efficacy and safety of ACTH (110 IU/m2 once daily for 15 days) and vigabatrin (100-150 mg/kg/daily in bid doses) was evaluated by a retrospective analysis of medical records of 42 infants (21 in each group) with infantile spasms and hypsarrhythmia treated at the Universite de Montreal, Hopital Sainte-Justine, Montreal, Canada.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The comparative efficacy and safety of ACTH (110 IU/m2 once daily for 15 days) and vigabatrin (100-150 mg/kg/daily in bid doses) was evaluated by a retrospective analysis of medical records of 42 infants (21 in each group) with infantile spasms and hypsarrhythmia treated at the Universite de Montreal, Hopital Sainte-Justine, Montreal, Canada.
Key concepts: Vigabatrin, Hypsarrhythmia, Medicine, Anesthesia, Medical record, Adrenocorticotropic hormone, Pediatrics, Epilepsy